HF
REGN icon

Halpern Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Halpern Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.08K Buy
+2
New +$2.23K ﹤0.01% 200

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Halpern Financial's REGN Position: Q3 2024 in Review

Halpern Financial opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 2 shares worth $2.08K. The stake represents ﹤0.01% of the portfolio and ranks #200 among its holdings.

1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Halpern Financial held 2 shares of Regeneron Pharmaceuticals worth $2.08K as of Q3 2024.
  • Regeneron Pharmaceuticals was a new Halpern Financial position in Q3 2024.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Halpern Financial's portfolio in Q3 2024, its #200 holding.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.